DGAP-News: RHÃN-KLINIKUM AG / Key word(s): Final Results/Quarter
Results
RHÃN-KLINIKUM AG: Results Press Conference in Frankfurt/Main on 28
April 2011
28.04.2011 / 07:00
---------------------------------------------------------------------
Results for financial year 2010
* Further 13.4% increase in patient treatments is proof of the trust in the
high quality of medical care offering.
* Growth in revenues of 9.9% and in earnings of 10.2% in 2010 demonstrate
the sustainability of growth course.
* Occupation of new buildings in GieÃen and Marburg in the first quarter of
2011. The investment commitments there - EUR 260 million from shareholder
funds - were fully met. GieÃen and Marburg are proof of investment
capability and innovative strength.
Q1 2011 results
* Continued rise in patient numbers by 69,839 cases or 13.7% to a total of
579,632 cases (previous year: 509,793 cases) underscores our good start
into the new financial year.
* Revenues climbed by 3.7% to reach EUR 647.2 million.
* Net consolidated profit rose by EUR 3.7 million or 10.8% to reach EUR
38.0 million.
* EBITDA rose by EUR 5.7 million or 7.8% to reach EUR 78.8 million.
* EBIT improved by EUR 3.8 million or 8.1% to EUR 50.6 million.
Forecast for the further course of 2011
The Company confirms its forecast for 2011. Despite a challenging
environment, the Company expects to generate revenues of roughly EUR 2.65
billion, an EBITDA of EUR 340 million and a net consolidated profit of
approximately EUR 160 million, with the last two figures potentially
fluctuating within a range of plus or minus 5%.
Bad Neustadt a. d. Saale/Frankfurt am Main, 28 April 2011
At its annual Results Press Conference today, the Board of Management of
RHÃN-KLINIKUM AG will confirm the trend figures already published in
February. 'We can look back on a successful financial year 2010. 'Patient
numbers have grown once again', said Wolfgang Pföhler, chairman of the
Board of Management of RHÃN-KLINIKUM AG. 'We are proud of the achievement
of our employees and facilities. The growing demand for our healthcare
services is proof of the trust people put in the high quality of our
medical offering. We have succeeded in continuing our growth in both the
outpatient and inpatient area. Our revenue and earnings targets were met as
expected. We once again succeeded in expanding our market share in 2010.
Our long-standing facilities report organic growth well above the emerging
national average. At the same time we stick to our policy of investing the
lion's share of our corporate profit in our hospitals and MVZs, - some 70%
of that profit is reinvested. That makes our investment ratio significantly
higher than that of any public operator. The reliability of our business
model was once again demonstrated. We can thus present a thoroughly
positive result for financial year 2010', Pföhler said.
Results for financial year 2010
In 2010, a total of more than two million patients were treated in the
Group's facilities. During the same period, revenues rose to EUR 2.55
billion. Net consolidated profit increased as forecast by 10.2% to EUR
145.1 million. Compared with last year, EBITDA was raised by 8.2% to EUR
307.3 million and EBIT by 8.7% to EUR 197.9 million. Operating cash flow
saw an increase of 7.4% to EUR 255.9 million.
The 13.4% rise in patient treatments was 'proof of the great trust in the
quality of our work'. With growth in revenues of 9.9% and in earnings of
10.2% in 2010, RHÃN-KLINIKUM AG moreover demonstrated the sustainability of
its growth course - also in times of crisis. Pföhler gave assurance that
this 'reliable' course would also be 'steadfastly' maintained in the new
financial year.
On 8 June 2011, the Board of Management and the Supervisory Board will
propose a dividend of EUR 0.37 (previous year: EUR 0.30) per ordinary
non-par share with dividend entitlement (DE 0007042301; 138,232,000 non-par
shares).
Jobs in 2010
As at 31 December 2010, RHÃN-KLINIKUM AG employed a total of 38,058 people
in ten federal states.
That is 1176 more than in the previous year. Above all doctors and nursing
staff were added. In many regions, the Group's facilities have come to be
amongst the largest employers.
Q1 2011 results
The Management is pleased with the start the Company has made into
financial year 2011. Already in the first three months, the Group treated
579,632 patients (+ 13.7%). Revenues rose to EUR 647.2 million (+3.7%). Net
consolidated profit rose 10.8% to reach EUR 38.0 million.
EBITDA climbed to EUR 78.8 million (+ 7.8%). EBIT stood at EUR 50.6
million, which translates into a rise of 8.1% versus the previous year's
level. As at 31 March 2011, the Group had 38,174 employees.
'The good first-quarter figures provide a very good starting point for
reliably reaching our forecast for full-year 2011', said Dr. Erik Hamann,
the Company's CFO.
To major projects were already successfully concluded in the first quarter.
At the University Hospital of GieÃen and Marburg two new buildings were put
into service. At both sites the moves were completed without any incidents.
Outlook for 2011:
Securing the future sustainability of good medical care is one of the key
aims pursued by the Group. Demographic trends and the related growing need
for high-quality medical care for the elderly present new challenges for
the healthcare system. 'We are committed to meeting these needs by creating
medical care offerings tailored to the individual needs of patients. We
have starting doing this by strengthening our medical care networks within
our Group, for example in acute geriatrics.
The groundwork for this has been laid with the acquisition of the Salze
Klinik hospital and the integration of a geriatric focus within our
hospital network - an outstanding medical concept in which we are once
again setting standards nationally. We are forging ahead with efforts to
implement viable and path-breaking service offerings.
At the same time, we continue to be committed to seeing through our
development from classic hospital operator to integrated healthcare
provider. The emerging structural transformation shows that we have come a
good way towards successfully completing the process begun two years ago:
advances in medicine and medical technology are giving rise to more and
more opportunities for outpatient treatment. There is hardly any better
example of how inpatient services are thus being shifted into the
outpatient segment than the specialist field of ophthalmology. We
identified the opportunities it holds early on, and are able to offer
patients innovative care services after our market entry into the field of
ophthalmology at the beginning of the year.
Right now the basis is being created for new legislation governing
outpatient care', explained the chairman of the Board of Management,
Wolfgang Pföhler. This new healthcare provision act has been prompted by
the shortage of doctors that is in the offing, especially in rural and
structurally weak regions.
As one of the largest providers of healthcare in Germany, RHÃN-KLINIKUM AG
wants to participate in shaping the required system change. And the Company
views the integration of outpatient and inpatient care and the creation of
attractive working conditions for doctors designed to harmonise family and
career as an important first step towards this goal.
'Good health means quality of life, which is the highest human good. In
2011 also, our objective is thus to offer generalised high-quality care
that is accessible and affordable for everyone', said Pföhler.
Contact:
Hans-Jürgen Heck
Head of Group Press and Public Relations
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Germany
Tel.: ++49 (0) 9771/ 65 - 1322
Fax: ++49 (0) 9771/ 65 - 1820
E-mail: hans-juergen.heck@rhoen-klinikum-ag.com
RHÃN-KLINIKUM AG is one of the largest healthcare providers in Germany. Its
corporate objective is high-quality medical care for everyone. Currently,
our Group counts 53 hospitals at 43 sites as well as 35 medical care
centres (MVZs) throughout Germany. We employ more than 38,000 persons. In
financial year 2010, more than two million patients were treated in the
Group's facilities.
Further information is available at: www.rhoen-klinikum-ag.com.
End of Corporate News
---------------------------------------------------------------------
28.04.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: RHÃN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
121729 28.04.2011
DGAP-News: RHÃN-KLINIKUM AG: Results Press Conference in Frankfurt/Main on 28 April 2011
| Source: EQS Group AG